IL1A and pulmonary fibrosis: However, this strong effect on inflammatory development was not concomitantly accompanied by a reduction of lung fibrosis, suggesting that inhibiting IL-1-driven inflammation may not be sufficient to control the fibrotic lung disease after particle exposure [76].